Skip to Content

TEVA 5553 (Dexmethylphenidate Hydrochloride Extended-Release 20 mg)

Pill with imprint TEVA 5553 is White, Capsule-shape and has been identified as Dexmethylphenidate Hydrochloride Extended-Release 20 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Dexmethylphenidate is used in the treatment of adhd and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dexmethylphenidate 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for TEVA 5553

Dexmethylphenidate hydrochloride extended-release 20 mg TEVA 5553
Dexmethylphenidate hydrochloride extended-release 20 mg TEVA 5553
Dexmethylphenidate hydrochloride extended-release 20 mg TEVA 5553

Dexmethylphenidate Hydrochloride Extended-Release

Imprint
TEVA 5553
Strength
20 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC)
00093-5553

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.